These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 23003678)

  • 21. Provider-based complementary and alternative medicine use among three chronic illness groups: associations with psychosocial factors and concurrent use of conventional health-care services.
    Sirois FM
    Complement Ther Med; 2008 Apr; 16(2):73-80. PubMed ID: 18514908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Time trends in therapies and outcomes for adult inflammatory bowel disease, Northern California, 1998-2005.
    Herrinton LJ; Liu L; Fireman B; Lewis JD; Allison JE; Flowers N; Hutfless S; Velayos FS; Abramson O; Altschuler A; Perry GS
    Gastroenterology; 2009 Aug; 137(2):502-11. PubMed ID: 19445944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of complementary and alternative medicine among patients with chronic diseases at outpatient clinics.
    Hasan SS; Ahmed SI; Bukhari NI; Loon WC
    Complement Ther Clin Pract; 2009 Aug; 15(3):152-7. PubMed ID: 19595416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complementary and alternative medicine use by Canadian patients with inflammatory bowel disease: results from a national survey.
    Hilsden RJ; Verhoef MJ; Best A; Pocobelli G
    Am J Gastroenterol; 2003 Jul; 98(7):1563-8. PubMed ID: 12873578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of phenotype at diagnosis and of other potential prognostic factors on the course of inflammatory bowel disease.
    Romberg-Camps MJ; Dagnelie PC; Kester AD; Hesselink-van de Kruijs MA; Cilissen M; Engels LG; Van Deursen C; Hameeteman WH; Wolters FL; Russel MG; Stockbrügger RW
    Am J Gastroenterol; 2009 Feb; 104(2):371-83. PubMed ID: 19174787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictive factors of complementary and alternative medicine use for patients with inflammatory bowel disease in Korea.
    Park DI; Cha JM; Kim HS; Park HJ; Shin JE; Hong SN; Hong SS; Kim WJ
    Complement Ther Med; 2014 Feb; 22(1):87-93. PubMed ID: 24559822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characteristics of complementary and alternative medicine use among adults with current asthma, 2006.
    Marino LA; Shen J
    J Asthma; 2010 Jun; 47(5):521-5. PubMed ID: 20536278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of complementary and alternative medicine by patients attending a general otolaryngology clinic: can we afford to ignore it?
    Shakeel M; Trinidade A; Jehan S; Ah-See KW
    Am J Otolaryngol; 2010; 31(4):252-60. PubMed ID: 20015757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sex differences in motives for use of complementary and alternative medicine among cancer patients.
    Hedderson MM; Patterson RE; Neuhouser ML; Schwartz SM; Bowen DJ; Standish LJ; Marshall LM
    Altern Ther Health Med; 2004; 10(5):58-64. PubMed ID: 15478787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COMPLEMENTARY AND ALTERNATIVE MEDICINE USE IN BRAZILIAN PATIENTS WITH INFLAMMATORY BOWEL DISEASE.
    Henriques DP; Oliveira RR; Vanni J; Lima HP; Otiti JV; Neves FRM; Hammerle MB; Sassaki LY; Zaltman C
    Arq Gastroenterol; 2022; 59(3):375-382. PubMed ID: 36102435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical characteristics of inflammatory bowel disease in Turkey: a multicenter epidemiologic survey.
    Tozun N; Atug O; Imeryuz N; Hamzaoglu HO; Tiftikci A; Parlak E; Dagli U; Ulker A; Hulagu S; Akpinar H; Tuncer C; Suleymanlar I; Ovunc O; Hilmioglu F; Aslan S; Turkdogan K; Bahcecioglu HI; Yurdaydin C;
    J Clin Gastroenterol; 2009 Jan; 43(1):51-7. PubMed ID: 18724251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complementary and alternative medicine use during early pregnancy.
    Pallivalappila AR; Stewart D; Shetty A; Pande B; Singh R; Mclay JS
    Eur J Obstet Gynecol Reprod Biol; 2014 Oct; 181():251-5. PubMed ID: 25190299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of MALTectomy (appendectomy and tonsillectomy) and inflammatory bowel disease: a familial case-control study.
    López Ramos D; Gabriel R; Cantero Perona J; Moreno Otero R; Fernández Bermejo M; Maté Jiménez J
    Rev Esp Enferm Dig; 2001 May; 93(5):303-14. PubMed ID: 11488108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Change of diagnosis during the first five years after onset of inflammatory bowel disease: results of a prospective follow-up study (the IBSEN Study).
    Henriksen M; Jahnsen J; Lygren I; Sauar J; Schulz T; Stray N; Vatn MH; Moum B;
    Scand J Gastroenterol; 2006 Sep; 41(9):1037-43. PubMed ID: 16938716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adverse clinical phenotype in inflammatory bowel disease: a cross sectional study identifying factors potentially amenable to change.
    van Langenberg DR; Lange K; Hetzel DJ; Holtmann GJ; Andrews JM
    J Gastroenterol Hepatol; 2010 Jul; 25(7):1250-8. PubMed ID: 20594252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complementary and alternative medicine use among Turkish diabetes patients.
    Ceylan S; Azal O; Taşlipinar A; Türker T; Açikel CH; Gulec M
    Complement Ther Med; 2009 Apr; 17(2):78-83. PubMed ID: 19185265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A national survey on the patterns of treatment of inflammatory bowel disease in Canada.
    Hilsden RJ; Verhoef MJ; Best A; Pocobelli G
    BMC Gastroenterol; 2003 Jun; 3():10. PubMed ID: 12791168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of clinical characteristics and management of inflammatory bowel disease in Hong Kong versus Melbourne.
    Prideaux L; Kamm MA; De Cruz P; Williams J; Bell SJ; Connell WR; Brown SJ; Lust M; Desmond PV; Chan H; Chow DK; Wu JC; Leong RW; Sung JJ; Chan FK; Ng SC
    J Gastroenterol Hepatol; 2012 May; 27(5):919-27. PubMed ID: 22098103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of alexithymia on health-related quality of life in inflammatory bowel disease: are there any related factors?
    Iglesias-Rey M; Barreiro-de Acosta M; Caamaño-Isorna F; Vázquez Rodríguez I; Lorenzo González A; Bello-Paderne X; Domínguez-Muñoz JE
    Scand J Gastroenterol; 2012 Apr; 47(4):445-53. PubMed ID: 22300356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of health-related quality of life and adherence in Crohn's disease and ulcerative colitis: implications for clinical management.
    Tabibian A; Tabibian JH; Beckman LJ; Raffals LL; Papadakis KA; Kane SV
    Dig Dis Sci; 2015 May; 60(5):1366-74. PubMed ID: 25559754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.